Ironwood Pharmaceuticals | IRWD - 流動負債





流動負債 変化する 日付
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Almirall EUR 350.64M 52.12M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amarin USD 194.46M 12.23M 2025-12
Ardelyx USD 88.6M 5.22M 2025-12
Astellas Pharma JPY 1.32T 873M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Coherus Biosciences USD 140.39M 231.91M 2025-12
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Lexicon Pharmaceuticals USD 20.87M 853K 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Moderna USD 1.99B 306M 2025-12
Myriad Genetics USD 133.8M 14.2M 2025-12
Pacira USD 120.59M 13.51M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12